Depression: A priority in public health;Depresión: Una prioridad en salud pública

Medicina Clinica

Volumn 123, Issue 5, 2004, Pages 181-186

  Ayuso Mateos, José Luis ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DEPRESSION; DISABILITY; ECONOMIC ASPECT; HUMAN; MAJOR DEPRESSION; REVIEW; SPAIN;

EID: 4043066425     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13064240     Document Type: Review

References (38)

1. Murray CJL, López A. The Global Burden of Disease. A comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge: Harvard School of Public Health, 1996.
2. Murray CJL, López A. Global Health Statistics: a compendium of incidence, prevalence and mortality estimates for over 200 conditions. Cambridge: Harvard School of Public Health, 1996.
3. WHO International Consortium in Psychiatric Epidemiology. Cross-National comparisons of the prevalences and correlates of mental disorders. WHO International Consortium in Psychiatric Epidemiology. Bull World Health Organ 2000;78:413-26.
4. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results From the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19.
5. Wittchen HU, Essau CA, Von Zerssen D, Krieg JC, Zaudig M. Lifetime and six-month prevalence of mental disorders in the Munich follow-Up Study. Eur J Epidemiol 1992;24:247-58.
6. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996;276:293-9.
7. Kendler KS, Walters EE, Kessler RC. The prediction of length of major depressive episodes: results from an epidemiological sample of female twins. Psychol Med 1997;27:107-17.
8. Ustun TB, Sartorious N, Mental illness in general health care: an international study. Chichester: John Wiley & Sons, 1995.
9. Wells KB, Stewart A, Hays RD. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA 1989;262:914-9.
10. Consultores para Europa Bernard Krief, Gabinete de Estudios Sociológicos. Libro blanco sobre la calidad asistencial de la depresión en España y la colaboración entre la psiquiatría y la asistencia primaria para su mejora. Madrid: Bernard Krief, 1997.
11. Kessler RC, Greenberg PE, Mickelson KD. The effects of chronic mental health conditions on work loss and work cut back. J Occup Environ Med 2001;43:218-25.
12. Almond S, Healey A. Mental health and absence from work. New evidence from the UK Quarterly Labour Force Survey. Work and Society 2003;17:731-42.
13. Thomas CE, Morris S. Cost of depression among adults in England in 2000. Br J Psychiatry 2003;183:514-9.
14. Murray CJL, López A. Alternative projections of mortality and disability by cause, 1990-220. Lancet 1997;349:1498-504.
15. Mathers C, Stein C, Ma Fat DM, Rao C, Inoue M, Tomijima N, et al. Global Burden of Disease 2000: Version 2 methods and results. Geneva: WHO, 2002.
16. World Health Organization. World Health Report 2001. Mental health: New understanding, new Hope. Geneva: World Health Organization, 2001.
17. World Health Organization. World Health Report 2002. Reducing risks, promoting healthy life. Geneva: World Health Organization, 2002.
18. Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJL. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004;184:386-92.
19. Ayuso-Mateos JL, Vázquez-Barquero JL, Dowrick C, Lehtinen V, Dalgard OS, Casey P, et al. Depressive disorders in Europe: prevalence figures from the ODIN Study. Br J Psychiatry 2001;179:308-16.
20. Vázquez-Barquero JL, Díez-Manrique JF, Pena C, Aldama J, Samaniego Rodriguez C, Menéndez Arango V, et al. Community mental health survey in Cantabria: a general description of morbidity. Psychol Med 1987;17:227-41.
21. Polaino-Lorente A, Mediano Cortes ML, Martínez J, Arias R, Epidemiological study of the symptomatology of childhood depression in Madrid school-age population. An Esp Pediatr 1997;46:344-50.
22. Canals J, Domenech E, Carbajo G, Blade J. Prevalence of DSM-III-R and ICD-10 psychiatric disorders in a Spanish population of 18-year-old. Acta Psychiatr Scand 1997;96:287-94.
23. Gili J, Ferrer V, Roca M, Bernardo M. Diferencias de género en un estudio epidemiologico de salud mental en población general en la isla de Formentera. Actas Luso Esp Neurol Psiquiatr Cienc Afines 1998;26:90-6.
24. Copeland JR, Beekman AT, Dewey ME., Hooijer C, Jordan A, Lawlor BA, et al. Depression in Europe. Geographical distribution among older people. Br J Psychiatry 1999;174:312-21.
25. Ayuso-Mateos JL, Lasa L, Vázquez-Barquero JL, Oviedo A, Díez-Manrique JF. Measuring health status in psychiatric community surveys: internal and external validity of the Spanish version of the SF-36. Acta Psychiatr Scand 1999;99:26-32.
26. Harris EC, Barraclough B, Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 1997;170:205-28.
27. Consultores para Europa Bernard Krief. Gabinete de Estudios Sociológicos. El coste social de los trastornos de salud mental en España. Madrid: Bernard Krief, 1998.
28. Alonso M, De Abajo, FJ, Martinez JJ, Montero D. Evolución del consumo de antidepresivos en España. Impacto de los inhibidores selectivos de la recaptación de serotonina. Med Clin (Barc) 1997;108:161-6.
29. Simon GE, Katon WJ, Von Korff M. Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. Am J Psychiatry 2001;158:1638-44.
30. Prieto L, Sacristán JA, Rubio C; Pinto JL, Antoñanzas F, Rovira J, por el grupo ECOMED. El analisis coste-efectividad en la evaluación económica de las intervenciones sanitarias. Med Clin (Barc) 2004;122:505-10.
31. Murray CJL, Evans, D, Acharya A, Baltussen R. Development of WHO guidelines on generalised cost-effectiveness analysis. Health Economics 2000;9:235-51.
32. Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, et al. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 2003;361:717-25.
33. World Health Organization. The World Health Report 2002; reducing risks, promoting healthy life. Geneva: WHO, 2002.
34. Chisholm D, Sanderson K, Ayuso-Mateos JL, Saxena S. Reducing the global burden of depression: a population-level analysis of intervention cost-effectiveness in 14 epidemiologically-defined sub-regions (WHO-CHOICE). Br J Psychiatry 2004;184:393-403.
35. Murray CJL, Lauer J, Hutubessy R, Niessen L, Tomjima N, Rodgers A, et al. Effectiveness and cost of interventions to lower systolic blood presure and cholesterol: a global and regional analysis on reduction of cardiovascular- disease Risk. Lancet 2003;361:717-25.
36. Commission on Macroeconomics and Health. Macroeconomics and health: Investing in health for economic development. Geneva: World Health Organization, 2001.
37. Ad Hoc Committee on Health Research Relating to Future Interventions Options. Investing in health research relating to future intervention options. Geneva: WHO, 1997.
38. Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity. A literature review. Arch Intern Med 2003;161:2433-45.